Search Results - "Piccini, Sara"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study by Piccini, Sara, Favacchio, Giuseppe, Panico, Cristina, Morenghi, Emanuela, Folli, Franco, Mazziotti, Gherardo, Lania, Andrea Gerardo, Mirani, Marco

    Published in Cardiovascular diabetology (25-03-2023)
    “…Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown cardiovascular benefits in cardiovascular outcome trials in type 2 diabetes mellitus. However,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists by Piccini, Sara, Favacchio, Giuseppe, Morenghi, Emanuela, Mazziotti, Gherardo, A. Lania, Andrea G., Mirani, Marco

    Published in Diabetes research and clinical practice (01-06-2024)
    “…[Display omitted] •Sex differences relative to CV protection with GLP-1 receptor agonists in type 2 diabetes patients are largely unknown.•The determinants of…”
    Get full text
    Journal Article
  4. 4

    Update on vertebral fractures in pituitary diseases: from research to clinical practice by Carrone, Flaminia, Ariano, Salvatore, Piccini, Sara, Milani, Davide, Mirani, Marco, Balzarini, Luca, Lania, Andrea Gerardo, Mazziotti, Gherardo

    Published in Hormones (Athens, Greece) (01-09-2021)
    “…Derangement of pituitary hormone axes can induce changes in bone remodeling and metabolism with possible alterations in bone microarchitectural structure and…”
    Get full text
    Journal Article
  5. 5

    Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms by Boemi, Ilena, Piccini, Sara, Colombo, Federico S., Smiroldo, Valeria, Zerbi, Alessandro, Capretti, Giovanni, Alloisio, Marco, Trivellin, Giampaolo, Lavezzi, Elisabetta, Mazziotti, Gherardo, Vitali, Eleonora, Lania, Andrea G.

    Published in Endocrine (01-03-2024)
    “…Purpose Neuroendocrine neoplasms (NENs) are tumors that arise from cells of the endocrine system and are most common in the gastrointestinal tract, the…”
    Get full text
    Journal Article
  6. 6

    Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment by Vitali, Eleonora, Boemi, Ilena, Tarantola, Giulia, Piccini, Sara, Zerbi, Alessandro, Veronesi, Giulia, Baldelli, Roberto, Mazziotti, Gherardo, Smiroldo, Valeria, Lavezzi, Elisabetta, Spada, Anna, Mantovani, Giovanna, Lania, Andrea G.

    Published in Cancers (02-08-2020)
    “…Introduction: Treatment options for neuroendocrine tumors (NETs) are rarely curative, as NETs frequently show resistance to medical therapy. The use of…”
    Get full text
    Journal Article
  7. 7

    AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus by Berra, Cesare, Manfrini, Roberto, Mirani, Marco, Bucciarelli, Loredana, Zakaria, Ahmed S., Piccini, Sara, Ghelardi, Renata, Lunati, Maria Elena, Rodovalho, Sylka, Bifari, Francesco, Fiorina, Paolo, Folli, Franco

    Published in Acta diabetologica (01-09-2023)
    “…Aim To describe the development of the AWARE App, a novel web application for the rapid assessment of cardiovascular risk in Type 2 Diabetes Mellitus (T2DM)…”
    Get full text
    Journal Article
  8. 8